Status:
RECRUITING
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Prematurity
Eligibility:
All Genders
Up to 18 years
Brief Summary
The purpose of this study is to develop biocompatible wireless electronic devices that will allow continuous, non-invasive hemodynamic and physiology measurements in the ICU.
Detailed Description
Screening: All ICU patients will be screened by the study team based on inclusion and exclusion criteria through review of electronic medical records. For screening at Prentice Women's Hospital, scree...
Eligibility Criteria
Inclusion
- Inclusion Criteria-ICU Population:
- Admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital
- Under 18 years of age
- Inclusion Criteria-Non-ICU Population
- Under 18 years of age
- Willing to visit the Center for Autonomic Medicine in Pediatrics (CAMP) for a one time study visit
- Exclusion Criteria-ICU Population:
- A skin abnormality that would potentially increase the risk of device
- 18 years of age or older
- Determined by an attending physician or bedside care team to be too unstable (patient) or experiencing too much stress (family)
- Exclusion Criteria-Non-ICU Population:
- A skin abnormality that would potentially increase risk of device use
- 18 years of age or older
Exclusion
Key Trial Info
Start Date :
March 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04723654
Start Date
March 15 2018
End Date
June 30 2026
Last Update
November 27 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611
2
Northwestern Medicine Prentice Women's Hospital
Chicago, Illinois, United States, 60611